What Happened?
San Diego, CA-based Plexium Appointed Daniel Sipes as Senior Vice President and Head of Technology
Date of management change: August 24, 2022
San Diego, CA-based Plexium Appointed Daniel Sipes as Senior Vice President and Head of Technology
Plexium is the premier, next-generation Targeted Protein Degradation (TPD) company seeking to discover a wide range of monovalent target protein degraders that address the limitations of heterobifunctional degraders and cereblon IMiDs. The company is powered by its proprietary drug discovery platform designed to identify novel small molecules that induce selective degradation of drug target proteins through E3 ligase mediated proteasomal degradation. From molecular glues to monovalent degraders, Plexium is advancing a pipeline of novel targeted protein degraders for the treatment of cancer, neurodegeneration, and other diseases. Due to its expertise in TPD, Plexium has entered into strategic collaborations with Amgen and AbbVie to discover and develop a wide range of new therapies from cancer to neurological diseases. Supported by high quality investors, Plexium is well positioned to transform medicine.
Daniel Sipes is Senior Vice President and Head of Technology at Plexium. Previously, Daniel held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Brown Bill, Haus Oron, Oberst Dave, Marr Bo, Millar Elijah, Cawley Joseph, Hall Jay, Soloway Robert, Helm Jeff, Neclerio Tom, Pielech Bradford
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.